Dynavax Technologies Corporation
DVAX
$10.97
$0.090.83%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.09% | 41.43% | |||
| Total Other Revenue | 37.87% | 11.39% | |||
| Total Revenue | -0.59% | 40.02% | |||
| Cost of Revenue | 94.90% | -48.18% | |||
| Gross Profit | -21.10% | 120.64% | |||
| SG&A Expenses | -20.89% | -14.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.40% | -12.04% | |||
| Operating Income | 41.07% | 177.81% | |||
| Income Before Tax | 33.95% | 121.68% | |||
| Income Tax Expenses | -40.20% | 240.48% | |||
| Earnings from Continuing Operations | 43.83% | 119.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 43.83% | 119.48% | |||
| EBIT | 41.07% | 177.81% | |||
| EBITDA | 38.50% | 188.46% | |||
| EPS Basic | 46.27% | 120.39% | |||
| Normalized Basic EPS | 36.27% | 240.63% | |||
| EPS Diluted | 43.07% | 118.73% | |||
| Normalized Diluted EPS | 35.91% | 221.27% | |||
| Average Basic Shares Outstanding | -1.68% | -4.45% | |||
| Average Diluted Shares Outstanding | -1.36% | 10.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||